New Novo drug delivers significant weight-loss benefits in diabetes trial
诺和诺德新药在糖尿病患者试验中显著促进减重

Amycretin also improved participants’ blood sugar levels in positive sign for Danish company’s treatment pipeline
Amycretin还改善了受试者的血糖水平，这对该丹麦公司的产品线而言是个积极信号。